WallStreetZenWallStreetZen

NASDAQ: OCUL
Ocular Therapeutix Inc Stock Ownership - Who owns Ocular Therapeutix?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ocular Therapeutix Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Todd AndermanChief Legal Officer2025-10-0811,132$12.34
$137.37kSell
Peter KaiserChief Development Officer2025-10-029,653$11.03
$106.47kSell
Jeffrey S. HeierChief Scientific Officer2025-10-0210,502$11.04
$115.94kSell
Donald NotmanOfficer2025-09-021,066$12.43
$13.25kSell
Pravin DugelExecutive Chairman President and CEO2025-08-2521,494$12.04
$258.79kSell
Sanjay NayakChief Strategy Officer2025-08-251,885$12.04
$22.70kSell
Jeffrey S. HeierChief Scientific Officer2025-08-253,063$12.04
$36.88kSell
Peter KaiserChief Development Officer2025-08-253,011$12.04
$36.25kSell
Nadia WaheedChief Medical Officer2025-06-0213,861$8.05
$111.58kSell
Sanjay NayakChief Strategy Officer2025-05-231,862$7.17
$13.35kSell

1 of 3

OCUL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OCUL insiders and whales buy or sell their stock.

OCUL Shareholders

What type of owners hold Ocular Therapeutix Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC11.27%19,608,171$225.10MInstitution
Deep Track Capital LP8.22%14,294,420$164.10MInstitution
Summer Road LLC7.98%13,887,468$159.43MInstitution
Vr Adviser LLC7.33%12,762,462$146.51MInstitution
Blackrock Inc6.06%10,546,379$121.07MInstitution
Opaleye Management Inc5.87%10,213,500$117.25MInsider
Summer Road LLC4.94%8,591,401$98.63MInsider
Vanguard Group Inc4.82%8,392,175$96.34MInstitution
Avoro Capital Advisors LLC4.25%7,400,000$84.95MInstitution
Tcg Crossover Management LLC3.06%5,319,148$61.06MInstitution

1 of 3

OCUL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OCUL81.08%18.92%Net SellingNet Selling
GLPG48.17%0.00%
MESO0.27%0.00%
LQDA47.48%52.52%Net SellingNet Selling
EWTX88.36%11.64%Net BuyingNet Selling
View Top Biotech Stocks

Ocular Therapeutix Stock Ownership FAQ

Who owns Ocular Therapeutix?

Ocular Therapeutix (NASDAQ: OCUL) is owned by 90.25% institutional shareholders, 21.06% Ocular Therapeutix insiders, and 0.00% retail investors. Opaleye Management Inc is the largest individual Ocular Therapeutix shareholder, owning 10.21M shares representing 5.87% of the company. Opaleye Management Inc's Ocular Therapeutix shares are currently valued at $120.72M.

If you're new to stock investing, here's how to buy Ocular Therapeutix stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.